Labile Plasma Iron Predicts for Survival in Patients Undergoing Allogeneic Stemcell-Transplantation – Results from the Prospective Multicenter German-Austrian Allive Trial. (April 2017) - Wermke, M.; Eckoldt, J.; Götze, K.S.; Klein, S.A.; de Wreede, L.C.; Bug, G.; Stölzel, F.; von Bonin, M.; Schetelig, J.; Laniado, M.; Plodeck, V.; Hofmann, W.K.; et al.